Page last updated: 2024-09-03

sq 28603 and Hypertension

sq 28603 has been researched along with Hypertension in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abboa-Offei, BE; Asaad, MM; Mathers, PD; Rogers, WL; Seymour, AA; Smith, PL1
Asaad, MM; Fennell, SA; Kratunis, VJ; Little, DK; Norman, JA; Rogers, WL; Seymour, AA1
Abboa-Offei, B; Asaad, MM; Delaney, NG; Di Donato, G; Fennell, SA; Hunt, JT; Kratunis, VJ; Little, DK; Norman, JA; Seymour, AA1

Reviews

1 review(s) available for sq 28603 and Hypertension

ArticleYear
Potentiation of natriuretic peptides by neutral endopeptidase inhibitors.
    Clinical and experimental pharmacology & physiology, 1995, Volume: 22, Issue:1

    Topics: Alanine; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Heart Failure; Hemodynamics; Hypertension; Neprilysin

1995

Other Studies

2 other study(ies) available for sq 28603 and Hypertension

ArticleYear
Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
    Journal of cardiovascular pharmacology, 1991, Volume: 17, Issue:2

    Topics: Alanine; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Cyclic GMP; Desoxycorticosterone; Diuresis; Hypertension; Infusions, Intravenous; Injections, Intravenous; Kidney; Male; Natriuresis; Neprilysin; Protease Inhibitors; Rats; Rats, Inbred Strains; Sodium Chloride

1991
Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 256, Issue:3

    Topics: Alanine; Animals; Atrial Natriuretic Factor; Blood Pressure; Desoxycorticosterone; Hypertension; Male; Neprilysin; Peptide Fragments; Rats; Rats, Inbred Strains

1991